Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Diabetes

Loss of β-cell mass — an acute event before T1DM presentation?

Loss of β-cell mass is posited to occur gradually over a long period of time in preclinical type 1 diabetes mellitus, as the first signs of β-cell autoimmunity generally emerge several years before clinical presentation. This concept has recently been challenged by observations of acute loss of β-cell mass in late-phase preclinical disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Knip, M. & Simell, O. Environmental triggers of type 1 diabetes. Cold Spring Harb. Perspect. Med. 2, a007690 (2012).

    Article  Google Scholar 

  2. Eisenbarth, G. S. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314, 1360–1368 (1986).

    Article  CAS  Google Scholar 

  3. Campbell-Thompson, M. et al. Insulitis and ß-cell mass in the natural history of type 1 diabetes. Diabetes 65, 719–731 (2016).

    Article  CAS  Google Scholar 

  4. Krogvold, L. et al. Function of isolated pancreatic islets from patients at onset of type 1 diabetes: insulin secretion can be restored after some days in a nondiabetogenic environment in vitro: results from the DiViD study. Diabetes 64, 2506–2512 (2015).

    Article  CAS  Google Scholar 

  5. Rodriguez-Calvo, T. et al. Increase in pancreatic proinsulin and preservation of beta cell mass in autoantibody positive donors prior to type 1 diabetes onset. Diabetes https://doi.org/10.2337/db16-1343 (2017).

  6. Ziegler, A. G. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309, 2473–2479 (2013).

    Article  CAS  Google Scholar 

  7. Salonen, K. et al. Autoantibodies against zinc transporter 8 correlate with age, metabolic state and HLA-DR genotype in children with newly diagnosed type 1 diabetes. Diabetes Metab. Res. Rev. 29, 646–654 (2013).

    Article  CAS  Google Scholar 

  8. Zimmet, P. Z. et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet. Med. 11, 299–303 (1994).

    CAS  PubMed  Google Scholar 

  9. Herold, K. et al. β cell death and dysfunction during type 1 diabetes development in at-risk individuals. J. Clin. Invest. 125, 1163–1174 (2015).

    Article  Google Scholar 

  10. Koskinen, M. et al. Reduced ß-cell function already in early preclinical type 1 diabetes. Eur. J. Endocrinol. 174, 251–259 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mikael Knip.

Ethics declarations

Competing interests

M.K. declares that he has received a lecture fee from Merck Sharpe & Dohme (MSD), and that he is a board member and minor share holder (<5%) of Vactech Oy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Knip, M. Loss of β-cell mass — an acute event before T1DM presentation?. Nat Rev Endocrinol 13, 253–254 (2017). https://doi.org/10.1038/nrendo.2017.33

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2017.33

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing